Browse Articles
Discover research articles across all indexed journals
Author Correction: Potential shared mechanisms in atopic dermatitis and type 2 diabetes identified via transcriptomic and machine learning approaches
ALK Tyrosine Kinase Inhibitors Induced Weight Gain: More Refined Definition of Weight Gain, Glucagon-Like Peptide-1 Agonist Treatment, and Therapeutic Drug Monitoring of <i>ALK+</i> Non–Small Cell Lung Cancer?
Utilizing non-invasive biomarkers for early and accurate differentiation of uncomplicated and complicated acute appendicitis: a retrospective cohort analysis
Reply to: Comment on the Definition and Interpretation of Complete Mesocolic Excision in the RELARC Trial
METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6A methylation of FAS
Body Weight Gain Associated With Alectinib in Patients With ALK+ Non–Small Cell Lung Cancer: Pooled Analysis of Individual Patient Data From Four Prospective Clinical Trials
PURPOSE Weight gain is a known adverse event (AE) of alectinib. This study evaluates the progression of actual weight gain over time and explores its association with baseline characteristics. METHODS A pooled analysis of individual patient data from four clinical trials (ALEX, J-ALEX, ALUR, and ML29453) was conducted. Actual weight gain was calculated as the percent change from baseline. A linear mixed model estimated weight change over time and associations between clinical characteristics and weight change. RESULTS Follow-up weights were available for three trials (J-ALEX, ALUR, and ML29453) and missing for ALEX. In total, 2,622 weights were recorded in the first year (N = 302). At baseline, 13.6% of the Japanese population were underweight and 5.0% in the Western population. Actual weight gain of any grade was substantially higher than reported AE rates (49% v 5%), with 18% experiencing ≥10% weight gain (from median 55.6 kg to 64.1 kg). Time on alectinib was positively associated with weight change (β = .37; 95% CI, 0.24 to 0.51; P < .001), corresponding to an average increase of 4.4% over 1 year. Baseline BMI was not associated with weight change in J-ALEX (β = –.090 [95% CI, –0.19 to 0.012]; P = .092) and ALUR/ML29453 (β = –.016 [95% CI, –0.077 to 0.044]; P = .59). Baseline albumin was positively associated with weight change in ALUR/ML29453 (β = .084 [95% CI, 0.027 to 0.14]; P = .0045), although not considered a clinically meaningful predictor. CONCLUSION Weight gain is under-reported as AE in trials. Actual weights showed ≥10% weight gain in 18% of patients. Clinicians should be aware of this AE, emphasizing the importance of timely identification and monitoring weight. Identifying predictors for weight gain remains challenging.
Reliability and validity of a self-developed virtual reality-based test battery for assessing motor skills in sports performance
Abstract Athletes must master various motor skills for success in their sports. To assess performance and identify areas of improvement, effective sports-motoric tests are essential. Key abilities such as reaction time, jumping, and complex movement coordination are critical. Virtual reality (VR) offers a practical, traditional equipment-free tool for assessment, though new VR-based tests must be evaluated first. We evaluated a self-developed test battery to measure reaction time (drop-bar test), jumping ability (jump and reach test), and parkour execution involving multiple complex motor tasks (with/without a virtual opponent). 32 participants completed these tests twice in real environment (RE) and VR (pre- and post-test). Intraclass correlation coefficients showed high reliability for reaction time in RE (0.858) and VR (0.888), with moderate significant correlations between them (r = .445), suggesting validity. The jump and reach test showed even better reliability (RE: 0.944, VR: 0.886) with strong correlations between RE and VR (r = .838). The parkour test showed lower reliability (x̄ 0.770), particularly for one task, with significant differences between the conditions indicating different behavior in VR. However, the addition of a virtual opponent eliminated these differences. VR appears to be a promising alternative to traditional testing methods, revealing comparable values across conditions.
Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial
PURPOSE The clinical efficacy of total neoadjuvant therapy (TNT) followed by selective nonoperative management (NOM) for locally advanced rectal cancer (LARC) was examined in the Organ Preservation for Rectal Adenocarcinoma (OPRA) trial. We investigated the cost and quality-of-life implications of adopting this treatment approach. METHODS We analyzed clinical, cost, and quality-of-life outcomes for TNT with selective NOM in comparison with chemoradiotherapy (CRT)-surgery-adjuvant chemotherapy (standard of care [SOC]) using data from OPRA, prospective cohorts, and published studies. Cost-effectiveness was evaluated over varying willingness-to-pay thresholds, and sensitivity analyses evaluated cost-effectiveness for different surgical contexts and SOC variants as well as a 10-year time horizon. RESULTS SOC was dominated by TNT with selective NOM in the base case analysis. TNT in which CRT was followed by consolidation chemotherapy (CNCT) was the least costly at $89,712 in Medicare proportionate US dollars (MP$), followed by TNT in which induction chemotherapy was followed by CRT (INCT) at MP$90,259 and SOC at MP$98,755. INCT was the preferred strategy, with 4.56 quality-adjusted life years, followed by CNCT at 4.42 and SOC at 4.29. TNT with selective NOM dominated SOC in all sensitivity analyses except when SOC omitted adjuvant chemotherapy without an impact on disease-free survival. CNCT was more cost effective than SOC when the proportion of patients entering NOM after TNT was ≥22% or ≥43%, for SOC with and without adjuvant therapy, both well below the rates seen in OPRA. CONCLUSION TNT with selective NOM is cost effective. The cost-effectiveness of CNCT with NOM relative to SOC is dependent on CNCT being made available to a sufficiently large proportion of patients with LARC. Additional analyses are needed to validate these findings from a societal perspective and in the context of other emerging treatment paradigms for LARC.
Enabling solid sample analysis in liquid spectrophotometers with a 3D-printed cuvette
Abstract Most commercial systems for ultraviolet-visible (UV–VIS), Fourier-transform infrared, circular dichroism (CD), and fluorescence spectroscopies are designed for measurement of liquid samples. Moreover, adapters enabling the measurement of solid samples are expensive or unavailable for most commercial instruments. Consequently, there is a significant need for solid sample adapters that enable measurement of both liquid and solid samples with a single system. Here, we report two versions of a solid sample adapter cuvette that can be used in most commercial spectroscopy instruments designed for transmission measurement of liquid samples. One version is designed for techniques that do not require changing the sample orientation, and the other allows easy sample rotation. We successfully fabricated these cuvettes by 3D printing with both fused deposition modeling and stereolithography and demonstrated how they enable us to study the optical properties of macroscopic films of aligned carbon nanotubes by performing UV–VIS and CD spectroscopy measurements with the cuvettes. These 3D printed cuvettes and their implementation will help enable a wide range of experiments at a low cost.
Significance of Up-Front Stereotactic Radiosurgery for Non–Small Cell Lung Cancer Patients With Brain Metastases in the Era of New Generation Tyrosine Kinase Inhibitors
Associations between cognitive activities and all-cause mortality among older adults with cognitive impairment: A prospective cohort study
Background Evidence on the association between cognitive activities and mortality among older adults with cognitive impairment is limited. Therefore, the study aimed to assess the association and examine whether baseline cognitive function mediates the association. Methods A total of 10477 older participants with cognitive impairment (median age: 95.0 [IQR: 88.0–100.0], males: 27.9%, Mini-Mental State Examination score ≤24 points) from the Chinese Longitudinal Healthy Longevity Survey conducted between 1998 and 2014 were included, with follow-up until 2018. Exposures were three prevalent cognitive activities among older adults in China: reading books/newspapers, playing cards/mah-jong, and watching TV or listening to radio, and the outcome was all-cause mortality within a 10-year follow-up period. We evaluated the association between these activities and mortality using Cox regression models and also conducted a mediation analysis to examine the role of baseline cognitive function in this association. Results During a follow-up period of totaling 33632.1 person-years, there were 8763 recorded deaths (83.6%). For each cognitive activity, the risk of mortality decreased with an increased frequency of engagement in these activities. Moreover, the risk of mortality significantly decreased with a greater number of cognitive activities. With zero activities as reference, adjusted hazard ratios were 0.83 (95% CI: 0.79–0.87) for one activity, 0.76 (95% CI: 0.69–0.83) for two activities, and 0.67 (95% CI: 0.53–0.86) for three activities, respectively. Stratified and sensitivity analyses confirmed the robustness of these findings. Additionally, baseline cognitive function partially mediated the association between cognitive activities and mortality; compared to zero activities, the mediated proportions were 15.2% (95% CI: 10.9%–22.4%) for one activity, 13.4% (95% CI: 8.9%–21.3%) for two activities, and 9.3% (95% CI: 4.2%–23.4%) for three activities, respectively. Conclusions Among older adults with cognitive impairment in China, the risk of all-cause mortality significantly decreased as both the frequency and number of cognitive activities increased. Baseline cognitive function only mediated a small proportion of the benefits of cognitive activities in longevity.
Predicting hepatocellular carcinoma survival with artificial intelligence
Stronger and coarser-grained biodegradable zinc alloys
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
PURPOSE Over the past 15 years, the landscape of early phase clinical trials (EPCTs) has undergone a remarkable expansion in both quantity and intricacy. The proliferation of sites, trials, sponsors, and contract research organizations has surged exponentially, marking a significant shift in research conduct. However, EPCT operations suffer from numerous inefficiencies, such as cumbersome start-up processes, which are particularly critical when drug safety and the recommended phase II dose need to be established in a timely manner. Networks and consortia may overcome some of these challenges of enrolling suitable patients and streamlining start-up, particularly when distance and disease trajectory come into play. DESIGN In this article, we provide an overview of EPCT consortia in adult oncology across different continents assembled through systematic review of the literature and snowball sampling methodology. We illustrate their scope, structure, funding, and achievements. RESULTS Fifteen EPCT consortia were identified including two in the United States, three in Europe, five in Asia-Pacific, two intercontinental consortia, and three within private oncology networks. These consortia vary in their scope, funding, and structure from government-funded models such as the National Cancer Institute Experimental Therapeutics Clinical Trials Networks through charitably funded and private research organizations. EPCT consortia play a role in collaborative research, molecular tumor boards to provide patient-centric biomarker-matched treatments, and streamlining trial conduct to improve timelines and cost efficiency. CONCLUSION The growth in EPCT activity and complexity has resulted in expansion in the number of EPCT consortia globally. By actively engaging with regulatory bodies and pharmaceutical and contract research organization industries, consortia have an opportunity to address the evolving challenges faced in this field and to accelerate the translation of scientific discoveries into clinical practice.
Sleep disturbances in older surgical patients with and without suspected cognitive impairment: A multicenter cohort study
Aims Early detection and management of sleep disturbances can improve postoperative outcomes given the high prevalence of sleep disturbances and unrecognized cognitive impairment in older surgical patients. There is an association between sleep disturbances and cognitive impairment in the general population. However, the relationship in older surgical patients has not been systematically investigated. The objective of this study was to assess the prevalence and trajectory of preoperative and postoperative sleep disturbances in older surgical participants with and without suspected cognitive impairment (sCI). Methods Two hundred and fifty-two participants aged ≥ 65 years undergoing non-cardiac surgery were recruited. The primary outcome was the prevalence and trajectory of sleep disturbances measured by the Pittsburgh Sleep Quality Index (PSQI) in participants with and without sCI preoperatively, 30, 90, and 180 days postoperatively. The main exposure, preoperative sCI, was operationalized as screening positive on one or more of the following cognitive screening tools: Centers for Disease Control and Prevention cognitive question (answered “yes”), Ascertain Dementia Eight-item Questionnaire (≥2), Telephone Montreal Cognitive Assessment (≤18), and Modified Telephone Interview for Cognitive Status (≤31). Sleep disturbances were defined as a PSQI score > 5. Mixed effects logistic regression models with random intercepts were used for the dichotomous outcome of sleep disturbances. Results One hundred and eight participants (43%) screened positive for preoperative sCI. The prevalence of preoperative sleep disturbances was higher in participants with sCI versus without (63% vs 47%, P = 0.02). Postoperatively in both groups, the prevalence of sleep disturbances was lower at 30, 90, and 180 days, compared to the preoperative assessment and overall trajectories did not differ significantly. Female sex and depression were associated with poorer postoperative sleep, regardless of cognitive status. Conclusion Sleep disturbances and suspected cognitive impairment are highly prevalent in surgical cohorts. Targeting conditions such as depression which affect sleep, may improve postoperative outcomes.
A real-world based study for immunogenicity and safety for three immunization schedules of polio vaccine
Abstract To evaluate the immunogencity and safety for three immunization schedules of inactivated poliovirus vaccine (IPV) and bivalent oral poliovirus vaccine (bOPV) for providing a basis for further optimization of the polio sequential immunization schedule. To obtain immunogenicity data and to active surveillance the occurrence of adverse events following immunization (AEFI), healthy infants ≥ 2 months of age were randomly chosen in Hebei Province, and were divided into three groups to be vaccinated with IPV-bOPV-bOPV(Group a), IPV-IPV-bOPV(Group b) and IPV-IPV-IPV(Group c) at 2, 3 and 4 months of age respectively. AEFI cases related to poliomyelitis vaccines in Hebei province by passive surveillance from January 1, 2018 to December 31, 2022 were obtained from national adverse event following immunization surveillance system (NAEFISS). After basic immunization with polio vaccine, the positive conversion rate of neutralizing antibodies of types I, II and III were all > 97.00% and the positive rates were all > 98.00%, the geometric mean titer (GMT) was significantly higher than that before basic immunization, the GMT level of neutralizing poliovirus antibody after basic immunization was the highest in type I, followed by type III, and the lowest in type II. A total of 16 AEFI cases (2.52%) were reported by active surveillance, and 2903 AEFI cases (1.40%) were reported by passive surveillance. AEFI reported by both monitoring modalities were dominated by fever of common vaccine reactions. No rare serious adverse reactions like VAPP etc. were monitored and the overall regression was positive. All three immunization schedules for polio vaccine have demonstrated good immunogenicity and safety when administered to healthy populations.
Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice
PURPOSE As part of the 100,000 Genomes Project, we set out to assess the potential viability and clinical impact of reporting genetic variants associated with drug-induced toxicity for patients with cancer recruited for whole-genome sequencing (WGS) as part of a genomic medicine service. METHODS Germline WGS from 76,805 participants was analyzed for pharmacogenetic (PGx) variants in four genes ( DPYD , NUDT15 , TPMT , UGT1A1 ) associated with toxicity induced by five drugs used in cancer treatment (capecitabine, fluorouracil, mercaptopurine, thioguanine, irinotecan). Linking genomic data with prescribing and hospital incidence records, a phenome-wide association study (PheWAS) was performed to identify whether phenotypes indicative of adverse drug reactions (ADRs) were enriched in drug-exposed individuals with the relevant PGx variants. In a subset of 7,081 patients with cancer, DPYD variants were reported back to clinicians and outcomes were collected. RESULTS We identified clinically relevant PGx variants across the four genes in 62.7% of participants in our cohort. Extending this to annual prescription numbers in England for the drugs affected by these PGx variants, approximately 14,540 patients per year could potentially benefit from a reduced dose or alternative drug to reduce the risk of ADRs. Validating PGx associations in a real-world data set, we found a significant association between PGx variants in DPYD and toxicity-related phenotypes in patients treated with capecitabine or fluorouracil. Reported DPYD variants were deemed informative for clinical decision making in a majority of cases. CONCLUSION Reporting PGx variants from germline WGS relevant to patients with cancer alongside primary findings related to their cancer can be clinically informative, informing prescribing to reduce the risk of ADRs. Extending the range of actionable variants to those found in patients of non-European ancestry is important and will extend the potential clinical impact.
Improved genetic algorithm based on greedy and simulated annealing ideas for vascular robot ordering strategy
This study presents a comprehensive approach for optimizing the acquisition, utilization, and maintenance of ABLVR vascular robots in healthcare settings. Medical robotics, particularly in vascular treatments, necessitates precise resource allocation and optimization due to the complex nature of robot and operator maintenance. Traditional heuristic methods, though intuitive, often fail to achieve global optimization. To address these challenges, this research introduces a novel strategy, combining mathematical modeling, a hybrid genetic algorithm, and ARIMA time series forecasting. Considering the dynamic healthcare environment, our approach includes a robust resource allocation model for robotic vessels and operators. We incorporate the unique requirements of the adaptive learning process for operators and the maintenance needs of robotic components. The hybrid genetic algorithm, integrating simulated annealing and greedy approaches, efficiently solves the optimization problem. Additionally, ARIMA time series forecasting predicts the demand for vascular robots, further enhancing the adaptability of our strategy. Experimental results demonstrate the superiority of our approach in terms of optimization, transparency, and convergence speed from other state-of-the-art methods. The source code is available at https://github.com/ybfo/improved-GA.
Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury
Open-source 3D printable forearm crutch
Although there has been considerable progress in distributed manufacturing of open-source designs for mobility aids, there is a notable lack of affordable, open-source crutches. Crutches are a vital tool for many individuals with mobility impairments, yet the high costs limit accessibility. Even more, they are in short supply in regions undergoing conflict. The goal of this study is to address this need by leveraging the principles of free and open-source hardware and the capabilities of digital distributed manufacturing to create a low-cost, functional crutch that can be easily produced and customized locally using inexpensive desktop 3D printers. All the design files are open-source, and the design process incorporated load-bearing tests using a hydraulic actuator under static loading conditions to meet the ISO 11334-1:2007 standard for walking aids. The open-source forearm crutch developed in this study not only surpasses the requirements of the ISO method for load capacity (1,516.3 ± 169.9 N, which is 51.6% percent above needs), weighs a fraction of comparable commercial systems (0.612 kg or 27% of proprietary devices), and is customizable, but also offers a highly cost-effective solution; costing CAD $36 in material, which is less than all equivalent crutches on the open market. If recycled plastic is used, the material cost of the crutch could be further reduced to under CAD $13, making it much more accessible.